Research: Literature Activity 9/10 · Very high (PubMed volume)
Data as of Nov 17, 2026 · Sources: Wikipedia pageviews, Reddit, X public mentions.
Measures online attention only. It is not a measure of quality, purity, efficacy, or safety.
Peptidea Deep Dive
RC-NAD Research Booklet
Deep-Dive Series · No. 5
PRB-NAD-001 Rev 1.1 · NAD+ · coenzyme · research reference
A view-only research booklet for approved, signed-in researchers. It opens in the Research Document Library viewer on peptidea.net, so you can read it without leaving this site.
Available in the Research Document Library after researcher approval.
Publications per year
Unique PubMed records grouped by publication year — a volume index, not a quality rating.
PubMed counts
Last updated Nov 17, 2026. 2,192 unique records for "nicotinamide adenine dinucleotide"[Title]. 2026 is a partial year. This is a title-restricted query (records from 1961 through 2026). A broader NAD search returns many more records; the query is shown so the volume index can be checked. Source on PubMed
Key specifications
Catalog facts are taken from the live PEPTIDEA™ listing. Formula and molecular weight are from PubChem. Sequence is omitted here.
Catalog title
RC-NAD | Mitochondrial Research
Research focus
Mitochondrial Research
Also described as
NAD+ · nicotinamide adenine dinucleotide
Format
Lyophilized research coenzyme (not a peptide)
Catalog status
In stock (public listing)
Presentations
500 and 1,000 mg vialsCatalog sizes, not a protocol
Molecular formula
C21H27N7O14P2PubChem CID 5892
Molecular weight
663.4PubChem average; exact mass 663.11
Receptor context
Dinucleotide coenzyme (redox and NAD-consuming enzymes)Literature description; research context only
Sequence
Not reproduced hereSee primary literature / PubChem
Researcher access
Sign-in required to view pricing
PubMed records
2,192 uniqueQuery above, Nov 17, 2026
Catalog notes & use limitations
Research-catalog framing only. This section does not describe effects in people or study outcomes.
Catalog notes
Listed under Mitochondrial Research
RC-NAD appears in the PEPTIDEA™ collection with other mitochondrial- and energy-focus materials, including RC-MOT and RC-LCARN. It is cataloged as a coenzyme, not a peptide.
Coenzyme research context
Published literature describes NAD+ as a dinucleotide cofactor in redox reactions and as a substrate of NAD-consuming enzymes. That is a biochemical-class description, not a use claim.
A very large literature exists
NAD+ biochemistry has been studied for decades. This page uses a title-restricted PubMed query so the volume index can be reproduced; it does not summarize experimental or clinical results.
Use limitations
Research use only
Not for human or veterinary use. Not a drug, not a cosmetic, and not medical advice. Not presented here as a treatment or weight-management product.
No outcome or dosing information
This page does not list administration amounts, schedules, or clinical results. Catalog vial sizes are presentations of the research material, not a protocol.
Confirm details from primary sources
Formula and molecular weight are cited from PubChem. Sequence is omitted. Read papers and the Deep Dive booklet for laboratory context — results stay in the original publications.
Specifications
Laboratory-catalog and public-chemistry details. Items without a cited source are marked.
Catalog title
RC-NAD | Mitochondrial Research
Category
Mitochondrial Research (Mitochondrial & Energy Research)
Associated names
NAD+; nicotinamide adenine dinucleotide
Format
Lyophilized research coenzyme (not a peptide)
Public catalog status
In stock (as of Nov 17, 2026)
Catalog presentations
500 and 1,000 mg vials — sizes of the research material, not a use protocol
Molecular formula
C21H27N7O14P2 (PubChem CID 5892, retrieved Nov 17, 2026)
Molecular weight
663.4 (PubChem average; exact mass 663.11)
InChIKey
BAWFJGJZGIEFAR-NNYOXOHSSA-N (PubChem)
Receptor context
Described in the literature as the oxidized dinucleotide coenzyme NAD+, used by dehydrogenases and as a substrate of NAD-consuming enzymes — research-class language only
Sequence
Not reproduced on this page. See primary literature and the PubChem record.
Pricing
Visible after researcher sign-in
PubChem lists CID 5892 under the compound title “Nadide.” That title is not used as a PEPTIDEA™ product name. This page refers to the material as NAD+ / nicotinamide adenine dinucleotide.
Peptidea Deep Dive
RC-NAD Research Booklet
Deep-Dive Series · No. 5
PRB-NAD-001 Rev 1.1 · NAD+ · coenzyme · research reference
A view-only research booklet for approved, signed-in researchers. It opens in the Research Document Library viewer on peptidea.net, so you can read it without leaving this site.
Available in the Research Document Library after researcher approval.
Research literature
These are Peptidea-written summaries of selected publications, prepared so you can stay on peptidea.net. Each card describes what was studied — the research question, study type, and mechanism or setting. We do not restate results, endpoints, or protocols. Full papers remain with their publishers; a small PubMed source link is included only for citation.
Review, microbial biochemistry
Foster and Moat
Microbiological Reviews · 1980
NAD biosynthesis and the pyridine nucleotide cycle in microbes
This review surveys nicotinamide adenine dinucleotide biosynthesis and pyridine nucleotide cycle metabolism as they were understood in microbial systems at the time of publication.
Pathway schemes and experimental observations cited in the review are not restated in detail here; the paper is included as a foundational biochemical reference.
This review discusses nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) as intermediates in NAD+ metabolism, and the biochemical routes by which they relate to the NAD+ pool.
Sections on proposed therapeutic potential and any outcome findings cited in the review are not reproduced on this page.
This review outlines nicotinamide adenine dinucleotide biosynthesis and consumption, and discusses how those pathways are framed in cardiac research models.
Disease-focused interpretations and any therapeutic suggestions in the paper are not restated here.
This experimental paper characterizes the nicotinamide adenine dinucleotide biosynthesis pathway and its regulatory mechanisms in the bacterium Streptococcus mutans.
Genetic and biochemical findings reported in the study are not restated on this page.
Structure-guided engineering of NadR for NAD production
This paper describes structure-guided engineering of the bifunctional enzyme NadR, with the stated aim of supporting nicotinamide adenine dinucleotide production.
Titer, activity, and process results reported in the paper are not reproduced here.
This paper reports an artificially designed pseudo-de novo biosynthesis pathway intended for nicotinamide adenine dinucleotide production in a microbial host.
Production titers and process metrics in the paper are not restated on this page.
Original titles are omitted or neutralized when they use clinical-outcome wording. Counts and the optional source links use the query "nicotinamide adenine dinucleotide"[Title]. Source on PubMed
Storage & handling
General laboratory-catalog guidance for layout purposes. Always follow the vial label and your institution’s written procedures.
Handle as a lyophilized research material intended for laboratory use only.
Store according to the conditions printed on the label and in any compound document provided to approved researchers.
Protect closed vials from moisture and unnecessary temperature swings.
If reconstitution is performed, use only the laboratory’s own written procedures. This page does not provide volumes, solvents, or working concentrations.
This material is not for human or veterinary use and is not medical advice.
No dosing, administration, or protocol instructions are included on this page.
Related compounds
Other PEPTIDEA™ materials currently listed under Mitochondrial Research on the public catalog.